Article
Phase I evaluation of all-trans-retinoic acid in adults with solid tumors.
1 May 1993
Abstract excerpt
PURPOSE: Prompted by recent demonstrations that all-trans-retinoic acid (all-trans-RA) had efficacy in acute promyelocytic leukemia, a phase I trial of all-trans-RA was conducted to establish the maximum-tolerated dose (MTD) before phase II testing. PATIENTS AND METHODS: Forty patients with a histologic or cytologic diagnosis of malignancy other than leukemia were treated with single daily oral doses of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
